Compare ANL & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANL | ZVIA |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Beverages (Production/Distribution) |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 193.4M |
| IPO Year | 2023 | 2021 |
| Metric | ANL | ZVIA |
|---|---|---|
| Price | $1.68 | $2.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $4.89 |
| AVG Volume (30 Days) | 35.9K | ★ 963.1K |
| Earning Date | 04-20-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $162,849,000.00 |
| Revenue This Year | N/A | $7.60 |
| Revenue Next Year | N/A | $6.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.17 |
| 52 Week Low | $0.88 | $1.88 |
| 52 Week High | $2.99 | $4.99 |
| Indicator | ANL | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | 60.08 | 36.39 |
| Support Level | $1.41 | $2.24 |
| Resistance Level | $1.61 | $2.69 |
| Average True Range (ATR) | 0.20 | 0.12 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 69.95 | 18.09 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.